Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | - |
Domain |
PF00443 Ubiquitin carboxyl-terminal hydrolase |
Function |
Has no peptidase activity. |
Biological Process |
GO:0016579 protein deubiquitination GO:0070646 protein modification by small protein removal |
Molecular Function |
GO:0008234 cysteine-type peptidase activity GO:0019783 ubiquitin-like protein-specific protease activity GO:0036459 thiol-dependent ubiquitinyl hydrolase activity GO:0101005 ubiquitinyl hydrolase activity |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between USP54 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of USP54 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of USP54 in various data sets.
|
Points in the above scatter plot represent the mutation difference of USP54 in various data sets.
|
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of USP54. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of USP54. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by USP54. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of USP54. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of USP54 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between USP54 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | USP54 |
Name | ubiquitin specific peptidase 54 |
Aliases | FLJ37318; bA137L10.3; bA137L10.4; C10orf29; chromosome 10 open reading frame 29; ubiquitin specific protease ...... |
Chromosomal Location | 10q22.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting USP54 collected from DrugBank database. |
There is no record. |